C.M. Bidwell & Associates »

Neurocrine Biosciences shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2026-06-30 $231k 1.4k 168.53
2023-09-30 $100k 889 112.50
2022-12-31 $50k 419 119.44
2022-09-30 $45k 419 107.40
2018-09-30 $34k 275 123.64

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
iShares Russell 2000 Index (IWM)
Vanguard Malvern Fds strm infproidx (VTIP)
Vanguard Total Stock Market ETF (VTI)
Schwab Strategic Tr sht tm us tres (SCHO)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
iShares S&P 500 Index (IVV)
Vanguard Europe Pacific ETF (VEA)
iShares MSCI ACWI ex US Index Fund (ACWX)
Ishares Tr core strm usbd (ISTB)
Vanguard Total Bond Market ETF (BND)
Dimensional Etf Trust (DFAC)
Schwab Strategic Tr us lrg cap etf (SCHX)
Schwab Strategic Tr 0 (SCHP)

View all positions for C.M. Bidwell & Associates

Top funds holding Neurocrine Biosciences

BlackRock
Jpmorgan Chase & Co
Dodge & Cox
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Vestal Point Capital
Bnp Paribas Investment Partners
Rtw Investments
Northern Trust
Morgan Stanley

View all funds holding Neurocrine Biosciences